The Discounted Cash Flow (DCF) valuation of Catalyst Pharmaceuticals Inc (CPRX) is 35.59 USD. With the latest stock price at 24.37 USD, the upside of Catalyst Pharmaceuticals Inc based on DCF is 46.1%.
Based on the latest price of 24.37 USD and our DCF valuation, Catalyst Pharmaceuticals Inc (CPRX) is a buy. buying CPRX stocks now will result in a potential gain of 46.1%.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 8.1% | 6.7% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 25.78 - 65.87 | 35.59 |
| Upside | 5.8% - 170.3% | 46.1% |